Facchetti’s study therefore suggested that claudin-4 may be a pan-carcinoma marker with high sensitivity and specificity and that this claudin protein may be considered a primary immunohistochemical marker to rule out the diagnosis of mesothelioma in patients with pleural and peritoneal biopsies and effusions [113]. Here, CLDN4 is linked to carcinoma.